About 3 results found for searched term "Lib2-1" (0.088 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10347 | Abemaciclib (LY2835219) | CDK |
| LY2835219 free base | ||
| Abemaciclib (LY2835219) is a best-in-class, selective and effective dual inhibitor of CDK4 and CDK6, which inhibits CDK4/CDK6 activity with IC50 of 2 nM and 10 nM respectively. | ||
| M15101 | Cemiplimab | PD-1/PD-L1 |
| Libtayo; REGN-2810; cemiplimab-rwlc | ||
| Cemiplimab (Libtayo) is a human monoclonal antibody injected intravenously that targets programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands PD-1 and PD-L2. Cemiplimab blocks T-cell inactivation and boosts the immune system's antitumor response. | ||
| M52849 | Lib2-1 | IL Receptor/Related |
| Lib2-1, a macrocyclic peptide, is an IL-17C/IL-17RE interaction inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
